Stay updated on Ralinepag Efficacy in PAH Patients Clinical Trial
Sign up to get notified when there's something new on the Ralinepag Efficacy in PAH Patients Clinical Trial page.

Latest updates to the Ralinepag Efficacy in PAH Patients Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe study record’s site listings were updated, with several locations in Argentina, Bulgaria, France, Hungary, Italy, Portugal, Spain, and Taiwan being refreshed in the Contacts and Locations section. The page’s record update dates and the site build/revision version also changed to reflect the latest update.SummaryDifference2%

- Check22 days agoNo Change Detected
- Check44 days agoChange DetectedRevision: v3.5.0 added and v3.4.3 removed. No user-visible changes to the study information.SummaryDifference0.0%

- Check51 days agoChange DetectedAdded numerous new trial sites across multiple countries (Taipei; Valencia; Madrid; Singapore; Porto District; Genova; Foggia; Budapest; Sofia; Córdoba Province; Ciudad Autónoma de Buenos Aires; Buenos Aires; and others) and removed several existing locations, altering the geographic footprint of participating centers.SummaryDifference2%

- Check59 days agoChange DetectedRevision update: v3.4.3 replaces v3.4.2 on the page. No visible changes to study details or page content are apparent.SummaryDifference0.0%

- Check66 days agoChange DetectedAdded 'Heritable pulmonary arterial hypertension' as a related topic/MeSH term in the study's contextual information.SummaryDifference0.0%

- Check73 days agoChange DetectedUpdated the study record with new dates: 2026-02-19 and 2026-02-20 were added, while 2026-02-05 and 2026-02-06 were removed.SummaryDifference0.1%

Stay in the know with updates to Ralinepag Efficacy in PAH Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ralinepag Efficacy in PAH Patients Clinical Trial page.